COMMUNIQUÉS West-GlobeNewswire

Aleafia to Launch Cannabis R&D Division Aleafia Labs
29/10/2018
Patient Data, Intellectual Property to be Used in Development of Proprietary Products TORONTO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. ( TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH ) (“ Aleafia “) or (the “Company [...]
Akorn Receives Product Approval
29/10/2018
LAKE FOREST, Ill., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, announced that, on October 26, 2018, it received a new Abbreviated New Drug [...]
Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials
29/10/2018
BUFFALO, N.Y., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
miRagen Therapeutics to Present at two Investor Conferences in November 2018
29/10/2018
BOULDER, Colo., Oct. 29, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, announced today [...]
Evofuel and Fantini s.r.l Announce Breakthrough in Mechanical Harvesting for Castor Bean
29/10/2018
Mechanical harvesting is a major bottleneck in conversion of castor bean to a fully modernized commercial crop; Combination of Fantini s.r.l Harvester with Evofuel proprietary varieties has demonstrated in field trials [...]
EyePoint Pharmaceuticals Presents Positive YUTIQ™ 24-month Follow-up Data at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting
29/10/2018
WATERTOWN, Mass., Oct. 29, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ: EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Sunesis Pharmaceuticals to Host Conference Call on November 5th to Discuss Third Quarter 2018 Financial Results and Recent Highlights
29/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Monday, November 5 th , 2018 at 4:30 p.m. Eastern Time [...]
Protalix BioTherapeutics to Hold Third Quarter 2018 Financial Results and Corporate Update Conference Call on November 7, 2018
29/10/2018
CARMIEL, Israel, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX, TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]
Innovate Biopharmaceuticals Announces Positive Effect of Larazotide Acetate on reducing Intestinal Permeability in a NASH Preclinical Study
29/10/2018
Top line results showed larazotide having a significant effect on intestinal permeability, a mechanism thought to be key for bacterial translocation leading to NAFLD/NASH Further preclinical data in combination with [...]
Tonix Pharmaceuticals will Present Phase 3 HONOR and Phase 2 AtEase Study Results in Poster Presentations at CNS Summit 2018
29/10/2018
NEW YORK, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced today that it will be presenting findings and retrospective analyses from the Phase 3 HONOR study and [...]
RedHill Biopharma to Host Analyst and Investor Webcast on TALICIA® for H. pylori infection on October 30, 2018
29/10/2018
Top-line results from the ERADICATE Hp2 confirmatory Phase III study expected before year-end 2018 H. pylori bacterial infection affects over 50% of the adult population worldwide and 30-40% of the U.S. population TEL- [...]
Amicus Therapeutics to Announce Third Quarter 2018 Financial Results on November 5, 2018
29/10/2018
CRANBURY, N.J., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Monday, November 5, 2018 at 8:30 a.m. ET to [...]
Vical Reports Third Quarter 2018 Financial and Operational Results
29/10/2018
SAN DIEGO, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three months ended September 30, 2018. Net loss for the third quarter of 2018 was $1.5 million, or $ [...]
Transactions under Novozymes’ stock buyback program
29/10/2018
Please read the full announcement in the attached PDF Attachment 2018_61_Stock_Buybackprogram_EN
AC Immune Partner Life Molecular Imaging Presents New Clinical Study Results for Tau PET-Tracer 18F-PI-2620
29/10/2018
Study confirms the good performance of tau PET-tracer 18 F-PI-2620 in detecting and quantifying tau deposition, a key pathological feature of Alzheimer's disease Results presented at the 11 th Clinical Trials on [...]
Dynavax to Host Third Quarter 2018 Financial Results Conference Call
29/10/2018
BERKELEY, Calif., Oct. 29, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that it will report financial results for the third quarter ended September 30, 2018 after market close [...]
AC Immune SA: New Data Supporting Crenezumab as Potential Alzheimer's Therapy
29/10/2018
Studies show that crenezumab protects neurons from Alzheimer's disease pathologies in vitro and further support the clinical rationale for crenezumab as a potential treatment for Alzheimer's disease Study on PET [...]
Aino Health AB (publ): Aino Health and Finla in new partnered delivery
29/10/2018
2018-10-29 Aino Health's strategic partner Finla has signed its first client contract regarding Aino HealthManager in Finland. The contract encompasses 3,000 new subscribers to Aino's SaaS solution HealthManager. The [...]
PIVOTAL TRIAL CONFIRMS LONG-TERM SAFETY AND EFFICACY OF IV IRON DOSING STRATEGY
29/10/2018
PIVOTAL TRIAL CONFIRMS LONG-TERM SAFETY AND EFFICACY OF INTRAVENOUS IRON DOSING STRATEGY ALLOWING HIGHER FERRITIN CONCENTRATION AND TRANSFERRIN SATURATION IN PATIENTS UNDERGOING HAEMODIALYSIS Results from the PIVOTAL [...]

Pages